Intuitive Surgical, Inc. $ISRG Shares Bought by Apexium Financial LP

Apexium Financial LP grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 504 shares of the medical equipment provider’s stock after buying an additional 32 shares during the period. Apexium Financial LP’s holdings in Intuitive Surgical were worth $274,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after buying an additional 453,335 shares in the last quarter. Invesco Ltd. boosted its holdings in shares of Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after buying an additional 71,794 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after buying an additional 11,988 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after buying an additional 457,080 shares in the last quarter. Finally, Nuveen LLC acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ISRG shares. Truist Financial upped their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. BTIG Research reiterated a “buy” rating and issued a $571.00 price target on shares of Intuitive Surgical in a research report on Wednesday. Finally, Piper Sandler reiterated an “overweight” rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $594.19.

Intuitive Surgical Stock Up 2.1%

Shares of ISRG opened at $452.35 on Friday. The company has a 50-day simple moving average of $463.55 and a 200-day simple moving average of $500.06. The company has a market capitalization of $162.16 billion, a PE ratio of 63.09, a P/E/G ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.78 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.